133 related articles for article (PubMed ID: 13837257)
1. In vivo monoamine oxidase inhibition measured by potentiation of tryptamine convulsions in rats.
TEDESCHI DH; TEDESCHI RE; FELLOWS EJ
Proc Soc Exp Biol Med; 1960 Apr; 103():680-2. PubMed ID: 13837257
[No Abstract] [Full Text] [Related]
2. Histochemical demonstration in rat of monoamine oxidase inhibition of beta-phenyl-isopropyl hydrazine.
MUSTAKALLIO KK; LEVONEN E; RAEKALLIO J
Science; 1961 Aug; 134(3475):344. PubMed ID: 13727138
[TBL] [Abstract][Full Text] [Related]
3. Studies on monoamine oxidase. 2: p-Methylphenyl hydrazine, a potent and selective monoamine oxidase inhibitor.
ARAI A
Jpn J Pharmacol; 1960 Mar; 9():159-68. PubMed ID: 13683948
[No Abstract] [Full Text] [Related]
4. Significance of monoamine oxidase inhibition for the pharmacological and clinical effects of hydrazine derivatives.
PLETSCHER A
Ann N Y Acad Sci; 1959 Sep; 80():1039-45. PubMed ID: 14433482
[No Abstract] [Full Text] [Related]
5. In vivo metabolism of serotonin and tryptamine: effect of monoamine oxidase inhibition.
WEISSBACH H; LOVENBERG W; REDFIELD BG; UDENFRIEND S
J Pharmacol Exp Ther; 1961 Jan; 131():26-30. PubMed ID: 13784114
[No Abstract] [Full Text] [Related]
6. Specific liver and brain monoamine oxidase inhibition by alkyl- and arylalkylhydrazines.
HORITA A; McGRATH WR
Proc Soc Exp Biol Med; 1960 Apr; 103():753-7. PubMed ID: 14403108
[No Abstract] [Full Text] [Related]
7. The route of administration of some hydrazine compounds as a determinant of brain and liver monoamine oxidase inhibition.
HORITA A
Toxicol Appl Pharmacol; 1961 Jul; 3():474-80. PubMed ID: 13715854
[No Abstract] [Full Text] [Related]
8. 2-SUBSTITUTED CYCLOPROPYLAMINES. II. EFFECT OF STRUCTURE UPON MONOAMINE OXIDASE-INHIBITORY ACTIVITY AS MEASURED IN VIVO BY POTENTIATION OF TRYPTAMINE CONVULSIONS.
ZIRKLE CL; KAISER C; TEDESCHI DH; TEDESCHI RE; BURGER A
J Med Pharm Chem; 1962 Nov; 5():1265-84. PubMed ID: 14056459
[No Abstract] [Full Text] [Related]
9. The pharmacological evaluation of monoamine oxidase inhibitors.
LESSIN AW
Biochem Pharmacol; 1959 Nov; 2():290-8. PubMed ID: 14416030
[No Abstract] [Full Text] [Related]
10. Anticonvulsant properties of monoamine oxidase inhibitors.
PROCKOP DJ; SHORE PA; BRODIE BB
Ann N Y Acad Sci; 1959 Sep; 80():643-51. PubMed ID: 14434994
[No Abstract] [Full Text] [Related]
11. Relative activity of some inhibitors of mono-amine oxidase in potentiating the action of tryptamine in vitro and in vivo.
MAXWELL DR; GRAY WR; TAYLOR EM
Br J Pharmacol Chemother; 1961 Dec; 17(3):310-20. PubMed ID: 14471627
[TBL] [Abstract][Full Text] [Related]
12. The effect of monoamine oxidase inhibitors and tryptophan on the tryptamine content of animal tissues and urine.
HESS SM; REDFIELD BG; UDENFRIEND S
J Pharmacol Exp Ther; 1959 Nov; 127():178-81. PubMed ID: 14401504
[No Abstract] [Full Text] [Related]
13. Biochemical and pharmacological effects of the monoamine oxidase inhibitors, iproniazid, 1-phenyl-2-hydrazinopropane (JB 516) and 1-phenyl-3-hydrazinobutane (JB 835).
SPECTOR S; SHORE PA; BRODIE BB
J Pharmacol Exp Ther; 1960 Jan; 128():15-21. PubMed ID: 13833205
[No Abstract] [Full Text] [Related]
14. A comparison of the in vivo inhibition of brain and liver monoamine oxidase as produced by beta-phenylisopropylhydrazine (PIH) and iproniazid.
GOGERTY JH; HORITA A
J Pharmacol Exp Ther; 1960 Aug; 129():357-60. PubMed ID: 13850477
[No Abstract] [Full Text] [Related]
15. [Inhibition "in vitro" of monoamine oxidase].
NARANJO R
Rev Asoc Medica Mex; 1960 Jun; 40():272-9. PubMed ID: 14426018
[No Abstract] [Full Text] [Related]
16. An in vivo test for measuring monoamine oxidase inhibition in human subjects.
RESNICK O; HAGOPIAN M; HOAGLAND H; FREEMAN H
AMA Arch Gen Psychiatry; 1960 Apr; 2():459-61. PubMed ID: 14437446
[No Abstract] [Full Text] [Related]
17. Reversal of the reserpine-induced depletion of brain serotonin by a monoamine oxidase inhibitor.
CANAL N; MAFFEI-FACCIOLI A
J Neurochem; 1959 Dec; 5():99-100. PubMed ID: 13807360
[No Abstract] [Full Text] [Related]
18. Theoretic background of therapy with monoamine oxidase inhibitors in cardiology.
ZBINDEN G
Am J Cardiol; 1960 Dec; 6():1121-4. PubMed ID: 13788034
[No Abstract] [Full Text] [Related]
19. [Pharmacological properties of a new inhibitor of monoamine oxidase: 2-hydrazino-1-phenylpropane].
GENOVESE E; ARRIGONI-MARTELLI E; FRESIA P
Farmaco Sci; 1959 Jul; 14():516-26. PubMed ID: 13849925
[No Abstract] [Full Text] [Related]
20. [Histochemical study of the action in vitro of serotonin, of tryptamine and some of their derivatives on rat brain monoamine oxidases].
Boucaud J; Bouchaud C; Couteaux R
C R Acad Hebd Seances Acad Sci D; 1967 Jan; 264(5):775-8. PubMed ID: 4989210
[No Abstract] [Full Text] [Related]
[Next] [New Search]
